The US organization ASCO has granted the David A. Karnofsky Memorial Award 2014 to Bob Pinedo, affiliated with the University of Twente as part-time Professor. Pinedo is honoured for, among other things, important discoveries within the biology of cancer and the effect of medication on patients.
Pinedo is highly praised for "his approach to quickly test new concepts in clinical trials. He has also made crucial discoveries about the biology of cancer and the effect of medication on patients, but also about the resistance that occurs."
Early diagnosis of cancer
Bob Pinedo is Emeritus Professor of the VU University Medical Center and the founder of, for example, the VUmc Cancer Center Amsterdam (CCA). He is also affiliated with the University of Twente MESA+ Institute for Nanotechnology, where he performs research into the early diagnosis of cancer along with Professor Albert van den Berg. Pinedo has put cancer research on the map in the Netherlands and beyond. When he started his career in the late nineteen seventies, the focus on cancer was confined to the two cancer institutes. Partly because of his work, a number of forms of cancer have now become a chronic disease that can be treated with medication.
David A. Karnofsky Memorial Award
The American Society of Clinical Oncology (ASCO) has, since 1970, each year presented the David A. Karnofsky Memorial Award to an oncologist who has made an indispensable contribution towards cancer research, diagnosis or treatment. The award is connected with a lecture during the annual ASCO congress. Pinedo will give this lecture on Saturday, 31 May at 9:30, during the opening of the congress.
More information about the award can be found on the ASCO website.
